Shenglong Chen

813 total citations
43 papers, 562 citations indexed

About

Shenglong Chen is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Shenglong Chen has authored 43 papers receiving a total of 562 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Cardiology and Cardiovascular Medicine and 11 papers in Epidemiology. Recurrent topics in Shenglong Chen's work include Sepsis Diagnosis and Treatment (8 papers), Neuroinflammation and Neurodegeneration Mechanisms (5 papers) and Intensive Care Unit Cognitive Disorders (5 papers). Shenglong Chen is often cited by papers focused on Sepsis Diagnosis and Treatment (8 papers), Neuroinflammation and Neurodegeneration Mechanisms (5 papers) and Intensive Care Unit Cognitive Disorders (5 papers). Shenglong Chen collaborates with scholars based in China, United States and Germany. Shenglong Chen's co-authors include Hongke Zeng, Hongguang Ding, Wenqiang Jiang, Xinqiang Liu, Miaoyun Wen, Yongli Han, Zhonghua Wang, Yunfei Chai, Xusheng Li and Ya Li and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Frontiers in Immunology and European Journal of Pharmacology.

In The Last Decade

Shenglong Chen

43 papers receiving 560 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shenglong Chen China	14	181	116	114	112	68	43	562
Yanna Si China	14	166 0.9×	146 1.3×	79 0.7×	79 0.7×	31 0.5×	36	653
Hongguang Bao China	17	133 0.7×	68 0.6×	104 0.9×	81 0.7×	54 0.8×	52	750
Dorien Kiers Netherlands	13	112 0.6×	36 0.3×	107 0.9×	113 1.0×	26 0.4×	20	549
Xiaotao Xu China	15	239 1.3×	57 0.5×	95 0.8×	21 0.2×	40 0.6×	27	584
M. Truschnig‐Wilders Austria	19	94 0.5×	92 0.8×	150 1.3×	101 0.9×	26 0.4×	21	749
Chi‐Ren Huang Taiwan	14	160 0.9×	46 0.4×	92 0.8×	36 0.3×	27 0.4×	22	708
Aizhong Wang China	14	228 1.3×	37 0.3×	103 0.9×	29 0.3×	42 0.6×	46	699
Feng Shen China	13	96 0.5×	30 0.3×	85 0.7×	27 0.2×	25 0.4×	61	493
Roop Gill United States	10	229 1.3×	58 0.5×	90 0.8×	25 0.2×	22 0.3×	11	661
Kathleen H. McDonough United States	18	232 1.3×	36 0.3×	147 1.3×	304 2.7×	29 0.4×	70	1.0k

Countries citing papers authored by Shenglong Chen

Since Specialization

Citations

This map shows the geographic impact of Shenglong Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shenglong Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shenglong Chen more than expected).

Fields of papers citing papers by Shenglong Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shenglong Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shenglong Chen. The network helps show where Shenglong Chen may publish in the future.

Co-authorship network of co-authors of Shenglong Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Shenglong Chen. A scholar is included among the top collaborators of Shenglong Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shenglong Chen. Shenglong Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Shenglong, Fan Lin, Jianhui Chen, et al.. (2025). Identification and characterization of 5 MYB transcription factors regulating the polydatin biosynthesis in Polygonum cuspidatum Sieb. et Zucc. Industrial Crops and Products. 226. 120612–120612. 1 indexed citations

Wang, Yifan, Fen Yao, Shenglong Chen, et al.. (2023). Optimal Teicoplanin Dosage Regimens in Critically Ill Patients: Population Pharmacokinetics and Dosing Simulations Based on Renal Function and Infection Type. Drug Design Development and Therapy. Volume 17. 2259–2271. 7 indexed citations

Chen, Shenglong, Xusheng Li, Jing Li, et al.. (2023). The expression of CD86 in CD3+CD56+ NKT cells is associated with the occurrence and prognosis of sepsis-associated encephalopathy in sepsis patients: a prospective observational cohort study. Immunologic Research. 71(6). 929–940. 3 indexed citations

Wang, Zhonghua, et al.. (2022). Pcv-aCO2 and procalcitonin levels for the early diagnosis of bloodstream infections caused by gram-negative bacteria. The American Journal of the Medical Sciences. 364(6). 752–757. 1 indexed citations

Xu, Jing, Xiangyin Chen, Bo Tan, et al.. (2022). A Two-Stage Bedside Intubation Method to Improve Success Rate of Post-pyloric Placement of Spiral Nasoenteric Tubes in Critically Ill Patients: A Multi-Center, Prospective Study. Frontiers in Medicine. 9. 875298–875298. 1 indexed citations

Wang, Xipei, Fen Yao, Shenglong Chen, et al.. (2021). Pharmacokinetics of Linezolid Dose Adjustment for Creatinine Clearance in Critically Ill Patients: A Multicenter, Prospective, Open-Label, Observational Study. Drug Design Development and Therapy. Volume 15. 2129–2141. 27 indexed citations

Liu, Shuo, Hui Ju, Feroze Mahmood, et al.. (2021). Pseudoaneurysm of Ascending Aorta induced by Brucella Endocarditis In bicuspid Aortic Valve. Echocardiography. 38(6). 1017–1020. 3 indexed citations

Zhou, Yuan, Linqiang Huang, Shenglong Chen, et al.. (2021). Optimal Targets of the First 24-h Partial Pressure of Carbon Dioxide in Patients with Cerebral Injury: Data from the MIMIC-III and IV Database. Neurocritical Care. 36(2). 412–420. 8 indexed citations

Wang, Zhonghua, Xuebiao Wei, Tiehe Qin, et al.. (2021). Prognostic value of central venous-to-arterial carbon dioxide difference in patients with bloodstream infection. International Journal of Medical Sciences. 18(4). 929–935. 2 indexed citations

10.

Chen, Shenglong, Hongguang Ding, Xinqiang Liu, et al.. (2020). JAK/STAT signaling pathway-mediated microRNA-181b promoted blood-brain barrier impairment by targeting sphingosine-1-phosphate receptor 1 in septic rats. Annals of Translational Medicine. 8(21). 1458–1458. 25 indexed citations

11.

Chen, Shenglong, Chaogang Tang, Hongguang Ding, et al.. (2020). Maf1 Ameliorates Sepsis-Associated Encephalopathy by Suppressing the NF-kB/NLRP3 Inflammasome Signaling Pathway. Frontiers in Immunology. 11. 594071–594071. 99 indexed citations

12.

Chen, Shenglong, Yunfei Chai, Zhonghua Wang, et al.. (2020). Effects of dexmedetomidine on heart rate control and pre-operative outcome in patients with acute aortic dissection: a propensity-matched analysis. Annals of Palliative Medicine. 9(5). 2886–2894. 3 indexed citations

13.

Liu, Xinqiang, Hongguang Ding, Xusheng Li, et al.. (2020). Hypercapnia Exacerbates the Blood–Brain Barrier Disruption Via Promoting HIF-1a Nuclear Translocation in the Astrocytes of the Hippocampus: Implication in Further Cognitive Impairment in Hypoxemic Adult Rats. Neurochemical Research. 45(7). 1674–1689. 12 indexed citations

14.

Wen, Miaoyun, Yongli Han, Linqiang Huang, et al.. (2018). Hypertonic saline regulates microglial M2 polarization via miR-200b/KLF4 in cerebral edema treatment. Biochemical and Biophysical Research Communications. 499(2). 345–353. 25 indexed citations

15.

Deng, Yujun, Shenglong Chen, Heng Ye, et al.. (2017). Evaluation of clinically available renal biomarkers in critically ill adults: a prospective multicenter observational study. Critical Care. 21(1). 46–46. 41 indexed citations

16.

Chen, Shenglong, Yiyu Deng, Yongli Han, et al.. (2017). Hypertonic saline protects brain endothelial cells against hypoxia correlated to the levels of estimated glomerular filtration rate and interleukin-1β. Medicine. 96(1). e5786–e5786. 4 indexed citations

17.

Liu, Xinqiang, et al.. (2016). Therapeutic effects of recombinant human brain natriuretic peptide on cardiac function in patients with septic shock. Zhonghua jizhen yixue zazhi. 25(10). 1263–1267. 1 indexed citations

18.

Chen, Yili, et al.. (2011). Acute myocardial ischemia directly modulates the expression of brain natriuretic peptide at the transcriptional and translational levels via inflammatory cytokines. European Journal of Pharmacology. 670(1). 7–12. 17 indexed citations

19.

He, Jiangui, et al.. (2009). B‐type natriuretic peptide attenuates cardiac hypertrophy via the transforming growth factor‐β1/smad7 pathway in vivo and in vitro. Clinical and Experimental Pharmacology and Physiology. 37(3). 283–289. 18 indexed citations

20.

He, Jiangui, Yili Chen, Fengjuan Yao, et al.. (2008). Effect of long-term B-type natriuretic peptide treatment on left ventricular remodeling and function after myocardial infarction in rats. European Journal of Pharmacology. 602(1). 132–137. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact